Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
07 November 2024
| Name: | ASIAN AMERICAN MEDICAL GROUP LIMITED (AJJ) | |||||||||
| ISIN: | AU000000AJJ5 | |||||||||
| Date of Listing: | 19 March 2007 | |||||||||
| Date of Delisting: | 24 November 2023 | |||||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 24 November 2023.Legal Status:
ACN: 091 559 125ABN: 42 091 559 125
Registration Date: 11 February 2000
Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| ASIAN AMERICAN MEDICAL GROUP LIMITED | 19/12/2012 | |
| ASIAN CENTRE FOR LIVER DISEASES AND TRANSPLANTATION LIMITED | 01/09/2009 | 19/12/2012 |
| COSTARELLA DESIGN LIMITED | 01/09/2009 |
REGISTRY:
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
Richard Albarran, Roberto Crispino and Aaron Dominish of Hall Chadwick appointed Administrators | 29/01/2024 |
delisted by ASX under Listing Rule 17.12 | 24/11/2023 |
we understand ASX removed the company from listing because its securities have been suspended from quotation for a continuous period of two years | 24/11/2023 |
The company lodges its August 2023 Quarterly Update. | 02/10/2023 |
The company lodges its Appendix 4C Quarterly Cash Flow Report. | 02/10/2023 |
The company lodges its May 2023 Quarterly Update. | 10/07/2023 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 22/06/2023 |
The company lodges its Half Yearly Report and Accounts. | 24/04/2023 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 30/03/2023 |
The company releases the results of its meeting. | 30/01/2023 |
The Company is expecting to receive an updated commitment from Saorsa Health No. 1 Pty Ltd to raise $3 million in capital through the placement of a total of 70,175,439 new fully paid ordinary shares in the Company at an issue price of A$0.0285 per New Share and the issue of 1,000,000 convertible notes at a face value of $1.00 each. Completion of the Placement has been delayed, but is now expected to occur in February 2023. It is expected that the funds for the Placement will be subscribed by Saorsa in February 2023 and that the issue of all New Shares under the Placement will occur at the same time in one tranche. It is anticipated that the issue of New Shares will occur shortly after receipt of subscription funds. | 30/01/2023 |
The company's AGM will be held on Monday, 30 January 2023 at 11.00am ACDT at 25 Peel Street, Adelaide, South Australia, Australia. | 03/01/2023 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 03/01/2023 |
The company releases an Appendix 4G. | 21/12/2022 |
The company lodges its Annual Report to shareholders. | 29/11/2022 |
The Company will hold its 2022 Annual General Meeting on: Monday, 16 January 2023 at 11.00am ACDT at Ground Floor 25 Peel Street ADELAIDE SA 5000. | 23/11/2022 |
The company releases a notice of proposed issue of securities. | 08/11/2022 |
A$3.0 million total capital raising, comprising A$2.0m by a share placement (approximately a quarter of which is subject to shareholder approval) and a A$1.0 million convertible note issue (subject to shareholder approval) to raise funds for working capital and business growth and reduce certain debt obligations. Reinvigoration of the Company's medical services business. Company seeks reinstatement of trading on the Australian Securities Exchange. | 07/11/2022 |
The company lodges its Appendix 4E Preliminary Final Report. | 28/10/2022 |
The company lodges its Half Year Accounts. | 29/04/2022 |
The clinical operations of wholly-owned subsidiary, Asian American Liver Centre Pte Ltd, has been relocated to 6 Napier Road, Gleneagles Medical Centre, #05-16, Singapore 258499, with effect from 18 April 2022. This follows the statutory demand and repossession of its premises at 6A Napier Road, Gleneagles Hospital Annexe Block, #02-37, Singapore 258500 by Parkway Hospital Singapore Pte Ltd against AALC for unpaid lease rentals. | 27/04/2022 |
The company releases the results of its meeting. | 19/01/2022 |
Given the sudden passing of Dr Tan the company has been delayed in the process of recruiting an Australian resident director. | 23/12/2021 |
The company's AGM will be held virtually on 19 January 2022 at 11.00 am Adelaide time. | 20/12/2021 |
The company made a correction to the date of its AGM. The Annual General Meeting will be held be held on Wednesday the 19th January 2022 at 11.00am Adelaide time by a virtual meeting. | 08/12/2021 |
The Board of Directors have decided to defer the annual general meeting of the company originally scheduled for Wednesday the 8th December 2021. The annual general meeting will now be held on Wednesday the 19th January 2021 at 11.00am Adelaide time by a virtual meeting. | 07/12/2021 |
The company releases its Corporate Governance Council Principles and Recommendations. | 25/11/2021 |
The securities of Asian American Medical Group Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of AJJ, pending the release of an announcement regarding the appointment of a sufficient number of directors to comply with section 201A(2) of the Corporations Act 2001 | 23/11/2021 |
name changed from Asian Centre for Liver Diseases and Transplantation Limited | 20/12/2012 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
Richard Albarran, Roberto Crispino and Aaron Dominish of Hall Chadwick appointed Administrators | 29/01/2024 |
delisted by ASX under Listing Rule 17.12 | 24/11/2023 |
we understand ASX removed the company from listing because its securities have been suspended from quotation for a continuous period of two years | 24/11/2023 |
The company lodges its August 2023 Quarterly Update. | 02/10/2023 |
The company lodges its Appendix 4C Quarterly Cash Flow Report. | 02/10/2023 |
The company lodges its May 2023 Quarterly Update. | 10/07/2023 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 22/06/2023 |
The company lodges its Half Yearly Report and Accounts. | 24/04/2023 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 30/03/2023 |
The company releases the results of its meeting. | 30/01/2023 |
The Company is expecting to receive an updated commitment from Saorsa Health No. 1 Pty Ltd to raise $3 million in capital through the placement of a total of 70,175,439 new fully paid ordinary shares in the Company at an issue price of A$0.0285 per New Share and the issue of 1,000,000 convertible notes at a face value of $1.00 each. Completion of the Placement has been delayed, but is now expected to occur in February 2023. It is expected that the funds for the Placement will be subscribed by Saorsa in February 2023 and that the issue of all New Shares under the Placement will occur at the same time in one tranche. It is anticipated that the issue of New Shares will occur shortly after receipt of subscription funds. | 30/01/2023 |
The company's AGM will be held on Monday, 30 January 2023 at 11.00am ACDT at 25 Peel Street, Adelaide, South Australia, Australia. | 03/01/2023 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 03/01/2023 |
The company releases an Appendix 4G. | 21/12/2022 |
The company lodges its Annual Report to shareholders. | 29/11/2022 |
The Company will hold its 2022 Annual General Meeting on: Monday, 16 January 2023 at 11.00am ACDT at Ground Floor 25 Peel Street ADELAIDE SA 5000. | 23/11/2022 |
The company releases a notice of proposed issue of securities. | 08/11/2022 |
A$3.0 million total capital raising, comprising A$2.0m by a share placement (approximately a quarter of which is subject to shareholder approval) and a A$1.0 million convertible note issue (subject to shareholder approval) to raise funds for working capital and business growth and reduce certain debt obligations. Reinvigoration of the Company's medical services business. Company seeks reinstatement of trading on the Australian Securities Exchange. | 07/11/2022 |
The company lodges its Appendix 4E Preliminary Final Report. | 28/10/2022 |
The company lodges its Half Year Accounts. | 29/04/2022 |
The clinical operations of wholly-owned subsidiary, Asian American Liver Centre Pte Ltd, has been relocated to 6 Napier Road, Gleneagles Medical Centre, #05-16, Singapore 258499, with effect from 18 April 2022. This follows the statutory demand and repossession of its premises at 6A Napier Road, Gleneagles Hospital Annexe Block, #02-37, Singapore 258500 by Parkway Hospital Singapore Pte Ltd against AALC for unpaid lease rentals. | 27/04/2022 |
The company releases the results of its meeting. | 19/01/2022 |
Given the sudden passing of Dr Tan the company has been delayed in the process of recruiting an Australian resident director. | 23/12/2021 |
The company's AGM will be held virtually on 19 January 2022 at 11.00 am Adelaide time. | 20/12/2021 |
The company made a correction to the date of its AGM. The Annual General Meeting will be held be held on Wednesday the 19th January 2022 at 11.00am Adelaide time by a virtual meeting. | 08/12/2021 |
The Board of Directors have decided to defer the annual general meeting of the company originally scheduled for Wednesday the 8th December 2021. The annual general meeting will now be held on Wednesday the 19th January 2021 at 11.00am Adelaide time by a virtual meeting. | 07/12/2021 |
The company releases its Corporate Governance Council Principles and Recommendations. | 25/11/2021 |
The securities of Asian American Medical Group Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of AJJ, pending the release of an announcement regarding the appointment of a sufficient number of directors to comply with section 201A(2) of the Corporations Act 2001 | 23/11/2021 |
name changed from Asian Centre for Liver Diseases and Transplantation Limited | 20/12/2012 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Evgeny Tugolukov | Non Exec Director | 03/06/2013 |
| Kong Ang | Non Exec Director | 22/02/2016 |
| Angela Choong | Executive Director, CFO | 20/01/2020 |
| Hamish Sprague | Executive Director | 23/01/2023 |
| Dario Nazzari | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Jeslyn Leong | Independent Director | 01/01/2012 | 30/01/2023 |
| Pang Yu | Independent Director | 08/01/2019 | 11/05/2022 |
| KC Tan | Executive Chairman, COO | 14/08/2009 | 06/12/2021 |
| Peter Hurley | Independent Director | 15/03/2019 | 16/11/2021 |
| Stuart Dean | Independent Director | 01/05/2018 | 04/01/2021 |
| Heng Fong | Independent Director | 14/08/2009 | 01/02/2020 |
| Cherinjit Shori | COO | 04/02/2010 | 31/01/2020 |
| Yeoh Meng Yau | CFO | 01/03/2013 | 20/01/2020 |
| Paul Yung | Independent Director | 31/01/2013 | 15/03/2019 |
| Wing Teh | Non Exec Director | 31/01/2011 | 12/01/2016 |
| Pamela Jenkins | Non Exec Director | 14/08/2009 | 30/09/2015 |
| Harry Lee | Director | 18/04/2011 | 05/02/2013 |
| Hoong Tang | Company Secretary | 14/08/2009 | 13/06/2011 |
| Ravindran Govindan | Non Exec Chairman | 06/02/2008 | 17/08/2009 |
| Richard Chan | Non Exec Director | 30/07/2008 | 17/08/2009 |
| Sam Di-Giacomo | Non Exec Director | 30/06/2006 | 17/08/2009 |
| Aurelio Costarella | Creative Director | 11/02/2000 | 17/08/2009 |
| Cathryn Curtin | Non Exec Director | 26/04/2006 | 26/02/2008 |
| Patty Chong | Non-Executive Chairperson | 29/08/2006 | 10/10/2007 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
